Neuromyelitis optica spectrum disorders.
Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A.
Clin Med (Lond). 2019 Mar;19(2):169-176. doi: 10.7861/clinmedicine.19-2-169.
Neuromyelitis optica.
Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B.
Nat Rev Dis Primers. 2020 Oct 22;6(1):85. doi: 10.1038/s41572-020-0214-9.
Optic neuritis: current challenges in diagnosis and management.
Benard-Seguin E, Costello F.
Curr Opin Neurol. 2023 Feb 1;36(1):10-18. doi: 10.1097/WCO.0000000000001128. Epub 2022 Dec 5.
The spectrum of neuromyelitis optica.
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.
Lancet Neurol. 2007 Sep;6(9):805-15. doi: 10.1016/S1474-4422(07)70216-8.
Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review.
Naphattalung Y, Chuenkongkaew WL, Chirapapaisan N, Laowanapiban P, Sawangkul S.
Ann Med. 2023 Dec;55(1):2227422. doi: 10.1080/07853890.2023.2227422.
Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y, Zhong L, Geng J.
Mult Scler Relat Disord. 2019 Jan;27:412-418. doi: 10.1016/j.msard.2018.12.002. Epub 2018 Dec 3.
Treatment of Neuromyelitis Optica Spectrum Disorders.
Chan KH, Lee CY.
Int J Mol Sci. 2021 Aug 11;22(16):8638. doi: 10.3390/ijms22168638.
Update on neuromyelitis optica spectrum disorder.
Holroyd KB, Manzano GS, Levy M.
Curr Opin Ophthalmol. 2020 Nov;31(6):462-468. doi: 10.1097/ICU.0000000000000703.
Optic neuromyelitis after vaccination against SARS-CoV-2.
Hernandez-Vega M, Orozco-Narvaez A, Reyes-Vaca JG, Rodriguez-Leyva I.
BMJ Case Rep. 2022 Dec 27;15(12):e252309. doi: 10.1136/bcr-2022-252309.
[Optic neuritis: aetiopathogenesis, diagnosis, prognosis and management].
Rodríguez-Acevedo B, Rovira A, Vidal-Jordana A, Moncho D, Pareto D, Sastre-Garriga J.
Rev Neurol. 2022 Feb 1;74(3):93-104. doi: 10.33588/rn.7403.2021473.
